Characterization of a Novel Monoclonal Antibody (27H2) Recognizing Human CD34 Class III Epitope

Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia. 27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines...

Full description

Saved in:
Bibliographic Details
Published inImmune network Vol. 10; no. 6; pp. 239 - 246
Main Authors Hong, Kwon-Pyo, Kang, Sung-Hee, Lee, Kyoung-Mee, Ji, Gil-Yong, Yoon, Sang-Soon, Kim, Jong-Suk, Son, Bo-Ra, Lee, Dong-Geun, Lee, Ok-Jun, Song, Hyung-Geun
Format Journal Article
LanguageEnglish
Published Korea (South) 대한면역학회 01.12.2010
The Korean Association of Immunologists
Subjects
Online AccessGet full text
ISSN1598-2629
2092-6685
2092-6685
DOI10.4110/in.2010.10.6.239

Cover

Abstract Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia. 27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines and peripheral blood, immunohistochemical study of frozen tonsil, we characterized 27H2 mAb. Antigen immunoprecipitated with 27H2 mAb immunobloted with anti-CD34 mAb. A case of bone marrow sample of acute lymphoblastic leukemia (ALL) patient was obtained at CBNU Hospital. For epitope identification enzyme treatment with neuraminidase and O-sialoglycoprotein endopeptidase (OSGE) and blocking assay with known classIII mAb (HPCA-2) were done. Only KG1 and Molm-1 revealed positive immunoreactivity. Immunohistochemical staining disclosed strong membranous immunoreactivity on high endothelial venules. Antigen immunoprecipitated by 27H2 mAb showed approximately 100 kDa sized band immunoblotted with anti-CD34 under non-reducing conditions. Epitope recognized by 27H2 mAb disclosed resistancy to both neuraminidase and OSGE treatment and completely blocked with known class III mAb preincubation. CD34 positive leukemic cells in BM of pre B cell ALL patient detected by FITC-conjugated 27H2 and HPCA-2 were identified with similar sensitivity. A novel murine mAb recognizing class III epitope of human CD34 with high affinity, which is useful for flow cytometric diagnosis of leukemia, was developed.
AbstractList Background: Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia. Methods: 27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines and peripheral blood, immunohistochemical study of frozen tonsil, we characterized 27H2 mAb. Antigen immunoprecipitated with 27H2 mAb immunobloted with anti-CD34 mAb. A case of bone marrow sample of acute lymphoblastic leukemia (ALL) patient was obtained at CBNU Hospital. For epitope identification enzyme treatment with neuraminidase and O-sialoglycoprotein endopeptidase (OSGE) and blocking assay with known classIII mAb (HPCA-2) were done. Results: Only KG1 and Molm-1 revealed positive immunoreactivity. Immunohistochemical staining disclosed strong membranous immunoreactivity on high endothelial venules. Antigen immunoprecipitated by 27H2 mAb showed approximately 100 kDa sized band immunoblotted with anti-CD34 under non-reducing conditions. Epitope recognized by 27H2 mAb disclosed resistancy to both neuraminidase and OSGE treatment and completely blocked with known class III mAb preincubation. CD34 positive leukemic cells in BM of pre B cell ALL patient detected by FITC-conjugated 27H2 and HPCA-2 were identified with similar sensitivity. Conclusion: A novel murine mAb recognizing class III epitope of human CD34 with high affinity, which is useful for flow cytometric diagnosis of leukemia, was developed. KCI Citation Count: 0
Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia. 27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines and peripheral blood, immunohistochemical study of frozen tonsil, we characterized 27H2 mAb. Antigen immunoprecipitated with 27H2 mAb immunobloted with anti-CD34 mAb. A case of bone marrow sample of acute lymphoblastic leukemia (ALL) patient was obtained at CBNU Hospital. For epitope identification enzyme treatment with neuraminidase and O-sialoglycoprotein endopeptidase (OSGE) and blocking assay with known classIII mAb (HPCA-2) were done. Only KG1 and Molm-1 revealed positive immunoreactivity. Immunohistochemical staining disclosed strong membranous immunoreactivity on high endothelial venules. Antigen immunoprecipitated by 27H2 mAb showed approximately 100 kDa sized band immunoblotted with anti-CD34 under non-reducing conditions. Epitope recognized by 27H2 mAb disclosed resistancy to both neuraminidase and OSGE treatment and completely blocked with known class III mAb preincubation. CD34 positive leukemic cells in BM of pre B cell ALL patient detected by FITC-conjugated 27H2 and HPCA-2 were identified with similar sensitivity. A novel murine mAb recognizing class III epitope of human CD34 with high affinity, which is useful for flow cytometric diagnosis of leukemia, was developed.
Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia.BACKGROUNDMonoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia.27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines and peripheral blood, immunohistochemical study of frozen tonsil, we characterized 27H2 mAb. Antigen immunoprecipitated with 27H2 mAb immunobloted with anti-CD34 mAb. A case of bone marrow sample of acute lymphoblastic leukemia (ALL) patient was obtained at CBNU Hospital. For epitope identification enzyme treatment with neuraminidase and O-sialoglycoprotein endopeptidase (OSGE) and blocking assay with known classIII mAb (HPCA-2) were done.METHODS27H2 mAb was developed from a mouse alternatively immunized with human acute leukemia cell lines, KG1 and Molm-1. Using flow cytometric analysis of various leukemic cell lines and peripheral blood, immunohistochemical study of frozen tonsil, we characterized 27H2 mAb. Antigen immunoprecipitated with 27H2 mAb immunobloted with anti-CD34 mAb. A case of bone marrow sample of acute lymphoblastic leukemia (ALL) patient was obtained at CBNU Hospital. For epitope identification enzyme treatment with neuraminidase and O-sialoglycoprotein endopeptidase (OSGE) and blocking assay with known classIII mAb (HPCA-2) were done.Only KG1 and Molm-1 revealed positive immunoreactivity. Immunohistochemical staining disclosed strong membranous immunoreactivity on high endothelial venules. Antigen immunoprecipitated by 27H2 mAb showed approximately 100 kDa sized band immunoblotted with anti-CD34 under non-reducing conditions. Epitope recognized by 27H2 mAb disclosed resistancy to both neuraminidase and OSGE treatment and completely blocked with known class III mAb preincubation. CD34 positive leukemic cells in BM of pre B cell ALL patient detected by FITC-conjugated 27H2 and HPCA-2 were identified with similar sensitivity.RESULTSOnly KG1 and Molm-1 revealed positive immunoreactivity. Immunohistochemical staining disclosed strong membranous immunoreactivity on high endothelial venules. Antigen immunoprecipitated by 27H2 mAb showed approximately 100 kDa sized band immunoblotted with anti-CD34 under non-reducing conditions. Epitope recognized by 27H2 mAb disclosed resistancy to both neuraminidase and OSGE treatment and completely blocked with known class III mAb preincubation. CD34 positive leukemic cells in BM of pre B cell ALL patient detected by FITC-conjugated 27H2 and HPCA-2 were identified with similar sensitivity.A novel murine mAb recognizing class III epitope of human CD34 with high affinity, which is useful for flow cytometric diagnosis of leukemia, was developed.CONCLUSIONA novel murine mAb recognizing class III epitope of human CD34 with high affinity, which is useful for flow cytometric diagnosis of leukemia, was developed.
Author Ji, Gil-Yong
Yoon, Sang-Soon
Kim, Jong-Suk
Lee, Ok-Jun
Son, Bo-Ra
Song, Hyung-Geun
Lee, Dong-Geun
Hong, Kwon-Pyo
Kang, Sung-Hee
Lee, Kyoung-Mee
AuthorAffiliation 3 Department of Laboratory Medicine, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea
1 Department of Pathology, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea
2 Research Institute, DiNonA Inc, Iksan 570-912, Korea
4 Department of Plastic and Reconstructive Surgery, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea
AuthorAffiliation_xml – name: 2 Research Institute, DiNonA Inc, Iksan 570-912, Korea
– name: 4 Department of Plastic and Reconstructive Surgery, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea
– name: 1 Department of Pathology, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea
– name: 3 Department of Laboratory Medicine, College of Medicine and Medical Research Institute, Chungbuk National University, Cheongju 361-763, Korea
Author_xml – sequence: 1
  fullname: Hong, Kwon-Pyo
– sequence: 2
  fullname: Kang, Sung-Hee
– sequence: 3
  fullname: Lee, Kyoung-Mee
– sequence: 4
  fullname: Ji, Gil-Yong
– sequence: 5
  fullname: Yoon, Sang-Soon
– sequence: 6
  fullname: Kim, Jong-Suk
– sequence: 7
  fullname: Son, Bo-Ra
– sequence: 8
  fullname: Lee, Dong-Geun
– sequence: 9
  fullname: Lee, Ok-Jun
– sequence: 10
  fullname: Song, Hyung-Geun
BackLink https://www.ncbi.nlm.nih.gov/pubmed/21286385$$D View this record in MEDLINE/PubMed
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001518585$$DAccess content in National Research Foundation of Korea (NRF)
BookMark eNp9kUtr3DAUhUVJaSZp910VbUrTxUz1sGRrUxicaceQJhDStbiW5YkajzSx7EDy66t5JLRdFAQXoe-cg-45QUc-eIvQe0pmGaXki_MzRtIlHTljXL1CE0YUm0pZiCM0oUIVUyaZOkYnMf4iRGY8F2_QMaOskLwQE6TLW-jBDLZ3TzC44HFoMeDL8GA7_CP4YLrgocNzP7g6NI_4jOVL9hlfWxNW3j05v8LLcQ0el-c8w2UHMeKqqvBi44awsW_R6xa6aN8d5in6-W1xUy6nF1ffq3J-MTWccDU1KmOsZTmRioncUlm0NQCRBWlymbdARZMbmhnJRQ68ZgpEI6HOAAqSKWr4KTrb-_q-1XfG6QBuN1dB3_V6fn1TabaNEgn9ukc3Y722jbF-6KHTm96toX_cCf9-8e422TxoTphUWZYMPh0M-nA_2jjotYvGdh14G8aoi0ylUgiVifzwZ9RLxvP-EyD3gOlDjL1ttXHDroeU7DpNid4WrZ3X26K3d5n-oZKQ_CN89v6P5ONhRWNCbePgRXN5db4gkiuWc8F_A4_StRg
CitedBy_id crossref_primary_10_1016_j_biomaterials_2015_07_012
Cites_doi 10.1016/0145-2126(85)90016-5
10.1200/JCO.1994.12.1.28
10.1016/S0022-1759(97)00045-8
10.1002/(SICI)1097-0320(19960615)26:2<154::AID-CYTO9>3.0.CO;2-G
10.1182/blood.V75.12.2417.2417
10.1089/scd.1.1992.1.115
10.1046/j.1365-2141.1996.7052322.x
10.1016/0145-2126(85)90082-7
10.1089/scd.1.1996.5.213
10.1111/j.1749-6632.1995.tb31046.x
10.3109/10428199509075299
10.1089/scd.1.1996.5.599
10.4049/jimmunol.133.1.157
ContentType Journal Article
Copyright Copyright © 2010 The Korean Association of Immunologists 2010
Copyright_xml – notice: Copyright © 2010 The Korean Association of Immunologists 2010
DBID DBRKI
TDB
AAYXX
CITATION
NPM
7X8
5PM
ACYCR
DOI 10.4110/in.2010.10.6.239
DatabaseName DBPIA - 디비피아
Nurimedia DBPIA Journals
CrossRef
PubMed
MEDLINE - Academic
PubMed Central (Full Participant titles)
Korean Citation Index
DatabaseTitle CrossRef
PubMed
MEDLINE - Academic
DatabaseTitleList
PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2092-6685
EndPage 246
ExternalDocumentID oai_kci_go_kr_ARTI_230395
PMC3026944
21286385
10_4110_in_2010_10_6_239
NODE06392735
Genre Journal Article
GroupedDBID 5-W
53G
8JR
8XY
9ZL
ACYCR
ADBBV
ADRAZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
DBRKI
DIK
E3Z
EF.
F5P
GW5
HYE
KQ8
KVFHK
M48
MZR
O5R
O5S
OK1
PGMZT
RPM
TDB
ZZE
AAYXX
CITATION
NPM
7X8
5PM
.UV
M~E
ID FETCH-LOGICAL-c3039-c9422f27069257e168fbaa0680d767fa15d7c14c6357a3b29a5d6ab4aa80491c3
IEDL.DBID M48
ISSN 1598-2629
2092-6685
IngestDate Tue Nov 21 21:36:43 EST 2023
Thu Aug 21 18:18:50 EDT 2025
Thu Jul 10 17:10:29 EDT 2025
Thu Apr 03 07:01:24 EDT 2025
Thu Apr 24 22:54:43 EDT 2025
Tue Jul 01 00:45:51 EDT 2025
Thu Mar 13 19:40:02 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Keywords 27H2
Class III epitope
Monoclonal antibody
Diagnosis
CD34
Leukemia
Language English
License This is an open access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c3039-c9422f27069257e168fbaa0680d767fa15d7c14c6357a3b29a5d6ab4aa80491c3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
G704-001562.2010.10.6.001
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.4110/in.2010.10.6.239
PMID 21286385
PQID 849010016
PQPubID 23479
PageCount 8
ParticipantIDs nrf_kci_oai_kci_go_kr_ARTI_230395
pubmedcentral_primary_oai_pubmedcentral_nih_gov_3026944
proquest_miscellaneous_849010016
pubmed_primary_21286385
crossref_citationtrail_10_4110_in_2010_10_6_239
crossref_primary_10_4110_in_2010_10_6_239
nurimedia_primary_NODE06392735
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20101201
PublicationDateYYYYMMDD 2010-12-01
PublicationDate_xml – month: 12
  year: 2010
  text: 20101201
  day: 1
PublicationDecade 2010
PublicationPlace Korea (South)
PublicationPlace_xml – name: Korea (South)
PublicationTitle Immune network
PublicationTitleAlternate Immune Netw
PublicationYear 2010
Publisher 대한면역학회
The Korean Association of Immunologists
Publisher_xml – name: 대한면역학회
– name: The Korean Association of Immunologists
References Watt (10.4110/in.2010.10.6.239_ref3) 1987; 1
Steen (10.4110/in.2010.10.6.239_ref21) 1996; 94
Katz (10.4110/in.2010.10.6.239_ref11) 1985; 9
Shpall (10.4110/in.2010.10.6.239_ref12) 1994; 12
Civin (10.4110/in.2010.10.6.239_ref6) 1995; 770
Serke (10.4110/in.2010.10.6.239_ref20) 1996; 26
Vescio (10.4110/in.2010.10.6.239_ref13) 1999; 93
Greaves (10.4110/in.2010.10.6.239_ref15) 1995
Beschorner (10.4110/in.2010.10.6.239_ref4) 1985; 119
Tindle (10.4110/in.2010.10.6.239_ref2) 1985; 9
Siena (10.4110/in.2010.10.6.239_ref10) 1991; 76
Titley (10.4110/in.2010.10.6.239_ref17) 1995; 16
Civin (10.4110/in.2010.10.6.239_ref14) 1989
Sutherland (10.4110/in.2010.10.6.239_ref26) 2000
Macey (10.4110/in.2010.10.6.239_ref24) 1997; 204
Sutherland (10.4110/in.2010.10.6.239_ref9) 1996; 5
Lanza (10.4110/in.2010.10.6.239_ref22) 1995; 18
Greaves (10.4110/in.2010.10.6.239_ref7) 1992; 6
Cannovo (10.4110/in.2010.10.6.239_ref19) 1997; 3
Fina (10.4110/in.2010.10.6.239_ref5) 1990; 75
Sovalat (10.4110/in.2010.10.6.239_ref25) 1998; 40
Sutherland (10.4110/in.2010.10.6.239_ref8) 1992; 1
Titley (10.4110/in.2010.10.6.239_ref18) 1995; 16
Nishio (10.4110/in.2010.10.6.239_ref16) 1997
Lanza (10.4110/in.2010.10.6.239_ref27) 2001; 15
Weinberg (10.4110/in.2010.10.6.239_ref23) 1996; 5
Civin (10.4110/in.2010.10.6.239_ref1) 1984; 133
1724439 - Haematologica. 1991 Jul-Aug;76(4):330-3
1693532 - Blood. 1990 Jun 15;75(12):2417-26
10068658 - Blood. 1999 Mar 15;93(6):1858-68
7505806 - J Clin Oncol. 1994 Jan;12(1):28-36
8817388 - J Hematother. 1996 Jun;5(3):213-26
1372379 - Leukemia. 1992;6 Suppl 1:31-6
7496351 - Leuk Lymphoma. 1995;18 Suppl 1:25-30
8528180 - Bone Marrow Transplant. 1995 Oct;16(4):611-6
8826880 - Br J Haematol. 1996 Sep;94(4):597-605
6586833 - J Immunol. 1984 Jul;133(1):157-65
3857408 - Leuk Res. 1985;9(2):191-8
11388737 - J Biol Regul Homeost Agents. 2001 Jan-Mar;15(1):1-13
9212835 - J Immunol Methods. 1997 May 26;204(2):175-88
2444831 - Leukemia. 1987 May;1(5):417-26
3857402 - Leuk Res. 1985;9(1):1-9
8597386 - Ann N Y Acad Sci. 1995 Dec 29;770:91-8
1285404 - J Hematother. 1992 Summer;1(2):115-29
8817092 - Cytometry. 1996 Jun 15;26(2):154-60
9117248 - J Hematother. 1996 Dec;5(6):599-603
3885751 - Am J Pathol. 1985 Apr;119(1):1-4
9924925 - Hematol Cell Ther. 1998 Dec;40(6):259-68
References_xml – volume: 9
  start-page: 1
  year: 1985
  ident: 10.4110/in.2010.10.6.239_ref2
  publication-title: Leuk Res
  doi: 10.1016/0145-2126(85)90016-5
– volume: 12
  start-page: 28
  year: 1994
  ident: 10.4110/in.2010.10.6.239_ref12
  publication-title: J Clin Oncol
  doi: 10.1200/JCO.1994.12.1.28
– start-page: 840
  volume-title: Leukocyte Typing V
  year: 1995
  ident: 10.4110/in.2010.10.6.239_ref15
– volume: 3
  start-page: 253
  year: 1997
  ident: 10.4110/in.2010.10.6.239_ref19
  publication-title: Lab Hematol
– volume: 204
  start-page: 175
  year: 1997
  ident: 10.4110/in.2010.10.6.239_ref24
  publication-title: J Immunol Methods
  doi: 10.1016/S0022-1759(97)00045-8
– volume: 26
  start-page: 154
  year: 1996
  ident: 10.4110/in.2010.10.6.239_ref20
  publication-title: Cytometry
  doi: 10.1002/(SICI)1097-0320(19960615)26:2<154::AID-CYTO9>3.0.CO;2-G
– volume: 75
  start-page: 2417
  year: 1990
  ident: 10.4110/in.2010.10.6.239_ref5
  publication-title: Blood
  doi: 10.1182/blood.V75.12.2417.2417
– volume: 16
  start-page: 611
  year: 1995
  ident: 10.4110/in.2010.10.6.239_ref18
  publication-title: Bone Marrow Transplant
– volume: 1
  start-page: 417
  year: 1987
  ident: 10.4110/in.2010.10.6.239_ref3
  publication-title: Leukemia
– start-page: 974
  volume-title: MC7. CD34 workshop panel report
  year: 1997
  ident: 10.4110/in.2010.10.6.239_ref16
– volume: 6
  start-page: 31
  issue: Suppl 1
  year: 1992
  ident: 10.4110/in.2010.10.6.239_ref7
  publication-title: Leukemia
– volume: 40
  start-page: 259
  year: 1998
  ident: 10.4110/in.2010.10.6.239_ref25
  publication-title: Hematol Cell Ther
– start-page: 818
  volume-title: M7.1. Report on the CD34 cluster workshop
  year: 1989
  ident: 10.4110/in.2010.10.6.239_ref14
– volume: 1
  start-page: 115
  year: 1992
  ident: 10.4110/in.2010.10.6.239_ref8
  publication-title: J Hematother
  doi: 10.1089/scd.1.1992.1.115
– start-page: 239
  volume-title: Bone Marrow Transplantation: A Practical Approach
  year: 2000
  ident: 10.4110/in.2010.10.6.239_ref26
– volume: 16
  start-page: 611
  year: 1995
  ident: 10.4110/in.2010.10.6.239_ref17
  publication-title: Bone Marrow Transplant
– volume: 94
  start-page: 597
  year: 1996
  ident: 10.4110/in.2010.10.6.239_ref21
  publication-title: Br J Haematol
  doi: 10.1046/j.1365-2141.1996.7052322.x
– volume: 9
  start-page: 191
  year: 1985
  ident: 10.4110/in.2010.10.6.239_ref11
  publication-title: Leuk Res
  doi: 10.1016/0145-2126(85)90082-7
– volume: 5
  start-page: 213
  year: 1996
  ident: 10.4110/in.2010.10.6.239_ref9
  publication-title: J Hematother
  doi: 10.1089/scd.1.1996.5.213
– volume: 770
  start-page: 91
  year: 1995
  ident: 10.4110/in.2010.10.6.239_ref6
  publication-title: Ann N Y Acad Sci
  doi: 10.1111/j.1749-6632.1995.tb31046.x
– volume: 15
  start-page: 1
  year: 2001
  ident: 10.4110/in.2010.10.6.239_ref27
  publication-title: J Biol Regul Homeost Agents
– volume: 76
  start-page: 330
  year: 1991
  ident: 10.4110/in.2010.10.6.239_ref10
  publication-title: Haematologica
– volume: 18
  start-page: 25
  issue: Suppl 1
  year: 1995
  ident: 10.4110/in.2010.10.6.239_ref22
  publication-title: Leuk Lymphoma
  doi: 10.3109/10428199509075299
– volume: 5
  start-page: 599
  year: 1996
  ident: 10.4110/in.2010.10.6.239_ref23
  publication-title: J Hematother
  doi: 10.1089/scd.1.1996.5.599
– volume: 93
  start-page: 1858
  year: 1999
  ident: 10.4110/in.2010.10.6.239_ref13
  publication-title: Blood
– volume: 119
  start-page: 1
  year: 1985
  ident: 10.4110/in.2010.10.6.239_ref4
  publication-title: Am J Pathol
– volume: 133
  start-page: 157
  year: 1984
  ident: 10.4110/in.2010.10.6.239_ref1
  publication-title: J Immunol
  doi: 10.4049/jimmunol.133.1.157
– reference: 1372379 - Leukemia. 1992;6 Suppl 1:31-6
– reference: 9212835 - J Immunol Methods. 1997 May 26;204(2):175-88
– reference: 8817092 - Cytometry. 1996 Jun 15;26(2):154-60
– reference: 7496351 - Leuk Lymphoma. 1995;18 Suppl 1:25-30
– reference: 1724439 - Haematologica. 1991 Jul-Aug;76(4):330-3
– reference: 2444831 - Leukemia. 1987 May;1(5):417-26
– reference: 3885751 - Am J Pathol. 1985 Apr;119(1):1-4
– reference: 8826880 - Br J Haematol. 1996 Sep;94(4):597-605
– reference: 11388737 - J Biol Regul Homeost Agents. 2001 Jan-Mar;15(1):1-13
– reference: 1693532 - Blood. 1990 Jun 15;75(12):2417-26
– reference: 8528180 - Bone Marrow Transplant. 1995 Oct;16(4):611-6
– reference: 9924925 - Hematol Cell Ther. 1998 Dec;40(6):259-68
– reference: 10068658 - Blood. 1999 Mar 15;93(6):1858-68
– reference: 8817388 - J Hematother. 1996 Jun;5(3):213-26
– reference: 1285404 - J Hematother. 1992 Summer;1(2):115-29
– reference: 9117248 - J Hematother. 1996 Dec;5(6):599-603
– reference: 6586833 - J Immunol. 1984 Jul;133(1):157-65
– reference: 3857408 - Leuk Res. 1985;9(2):191-8
– reference: 7505806 - J Clin Oncol. 1994 Jan;12(1):28-36
– reference: 3857402 - Leuk Res. 1985;9(1):1-9
– reference: 8597386 - Ann N Y Acad Sci. 1995 Dec 29;770:91-8
SSID ssj0064375
Score 1.747581
Snippet Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia. 27H2 mAb was developed from a mouse...
Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia.BACKGROUNDMonoclonal antibodies...
Background: Monoclonal antibodies (mAbs) recognizing Class III epitope of CD34 are essential for flow cytometric diagnosis of leukemia. Methods: 27H2 mAb was...
SourceID nrf
pubmedcentral
proquest
pubmed
crossref
nurimedia
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 239
SubjectTerms Original
면역학
Title Characterization of a Novel Monoclonal Antibody (27H2) Recognizing Human CD34 Class III Epitope
URI https://www.dbpia.co.kr/journal/articleDetail?nodeId=NODE06392735
https://www.ncbi.nlm.nih.gov/pubmed/21286385
https://www.proquest.com/docview/849010016
https://pubmed.ncbi.nlm.nih.gov/PMC3026944
https://www.kci.go.kr/kciportal/ci/sereArticleSearch/ciSereArtiView.kci?sereArticleSearchBean.artiId=ART001518585
Volume 10
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
ispartofPNX Immune Network, 2010, 10(6), , pp.239-246
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhR1da9swUKwdY3sZ-172ETTYw_rg1JJlWX4aI01JBs1gLNA3IclyZxrkNE3Ksl-_Ozv1lhE2MDbGJ9nW6XR3ui9C3itZcCdTAYSUmQgzUkWqKFmUS2eLPI298xjvfDaV45n4fJ6e_w6P3g7g9V7VDutJzZbzwY-rzUcgeJBfBwK413EVWhctOOSAJ_kBuQt8SaIqdiY6mwJaqNChkcc5j6RUaWu03NvDDpM6CEs43w9rzLcPSNsni_7tUvkHjzp9RB5uhUv6qZ0Nj8kdH56Qe225yc1TooddduY2-JLWJTV0Wt_4OQXirt28btqHVWXrYkM_8GzMj-jX1snoJ3A52mz60-FJImhTT5NOJhM6WsC6sPDPyOx09G04jrYFFiKXoAXY5YLzkmexzIFyPZOqtMZgNY4ik1lpWFpkjgmHOetMYnlu0kIaK4xRoFgwlzwnh6EO_iWhsS-tLwvQ3ywTXnGbpz5TBWOJij3zrkeOb0dUu232cSyCMdeghSAOdBU04gDvpQYc9MhR12LRZt74B-w7QJK-dJXGdNl4vaj15VKDUjABAPjZtEf6HQq7DqdfTkYopIEQBwD0Fq8aaAwNJyb4en2tlUAnFhCOe-RFi-auA-D8CpYwaJztTIAOAL9n90movjdpvJMYo4jFq_-_9jV5wDsvmjfkcLVc-7cgC61sv5ni_WaT6hdu4QQW
linkProvider Scholars Portal
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Characterization+of+a+Novel+Monoclonal+Antibody+%2827H2%29+Recognizing+Human+CD34+Class+III+Epitope&rft.jtitle=Immune+network&rft.au=Hong%2C+Kwon+Pyo&rft.au=Kang%2C+Sung+Hee&rft.au=Lee%2C+Kyoung-Mee&rft.au=Ji%2C+Gil+Yong&rft.date=2010-12-01&rft.issn=2092-6685&rft.eissn=2092-6685&rft.volume=10&rft.issue=6&rft.spage=239&rft_id=info:doi/10.4110%2Fin.2010.10.6.239&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1598-2629&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1598-2629&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1598-2629&client=summon